Prospective, randomised, double blind, controlled comparison of metoclopramide and pethidine in the emergency treatment of acute primary vascular and tension type headache episodes

M Cicek, O Karcioglu, I Parlak, V Ozturk, O Duman, M Serinken, M Guryay, M Cicek, O Karcioglu, I Parlak, V Ozturk, O Duman, M Serinken, M Guryay

Abstract

Study objective: To compare analgesic effects of metoclopramide (MTP), pethidine (PET), and combination of metoclopramide-pethidine (M-PET) in the treatment of adult patients with acute primary vascular and tension type headache admitted in the emergency department (ED).

Methods: All consecutive adult patients admitted into a university hospital ED in six months with acute vascular and tension type headache were recruited. The patients whose complaints had lasted no longer than seven days were randomised to four groups and thereby received 10 mg MTP intravenously plus placebo intramuscularly (MTP), 10 mg MTP intravenously plus 50 mg PET intramuscularly (M-PET), 50 mg PET intramuscularly plus placebo intravenously (PET); and intramuscular and intravenous placebo (PLC) in a blinded fashion. The patients were asked to report the degree of pain at 0, 15, 30, and 45 minutes on visual analogue scale (VAS) and demographic data and any side effects encountered were recorded. Rescue medication was used if required by the patient because of poor pain relief.

Results: Data regarding 336 patients meeting inclusion criteria were analysed. Mean VAS values recorded at 45 minutes were significantly higher in PLC group than in others (p = 0.000). When the PLC group was excluded, VAS scores in MTP and M-PET groups were significantly lower than in PET group (p = 0.038). Though unimportant, the incidence of side effects recorded in PET group was found to be significantly higher than in the other groups (p = 0.003).

Conclusion: These data suggest that MTP produces more effective analgesia than PET in both vascular and tension type headache in patients with acute primary headache episodes.

References

    1. Am J Ophthalmol. 1996 Jan;121(1):96-7
    1. Acad Emerg Med. 1995 Jul;2(7):597-602
    1. Am J Emerg Med. 1996 May;14(3):262-4
    1. Pathol Biol (Paris). 1995 Nov;43(9):806-13
    1. Headache. 1996 Jun;36(6):352-6
    1. Headache. 1997 Jul-Aug;37(7):452-4
    1. Neurology. 1998 Feb;50(2):507-9
    1. Ann Emerg Med. 1998 Aug;32(2):129-38
    1. Emerg Med Clin North Am. 1998 Nov;16(4):741-60, vi
    1. Neurology. 1989 Apr;39(4):590-2
    1. Ann Emerg Med. 1989 Apr;18(4):360-5
    1. Ann Emerg Med. 1990 Oct;19(10):1083-7
    1. Ann Emerg Med. 1991 Nov;20(11):1201-5
    1. Ann Emerg Med. 1992 Aug;21(8):985-6
    1. Ann Emerg Med. 1993 Feb;22(2):191-5
    1. Headache. 1993 Nov-Dec;33(10):560-2
    1. Cephalalgia. 1994 Aug;14(4):297-300
    1. Am J Emerg Med. 1995 Mar;13(2):146-50
    1. Presse Med. 1995 Feb 4;24(5):254-8
    1. Headache. 1995 May;35(5):256-9
    1. Ann Emerg Med. 1995 Nov;26(5):541-6
    1. Headache. 1995 Nov-Dec;35(10):637-8
    1. Ann Emerg Med. 1996 Apr;27(4):448-50

Source: PubMed

3
订阅